Page 18 - Read Online

93. Garcia A, Singh H. Bevacizumab and ovarian cancer. Ther Adv Med nanoparticles to optimize PK/PD interactions of combined anti-
Oncol 2013;5:133-41. cancer therapies. Curr Drug Metab 2014;15:818-28.
94. Krishnamurthy S, Ke X, Yang YY. Delivery of therapeutics using 101. Swaminathan SK, Roger E, Toti U, Niu L, Ohlfest JR, Panyam J.
nanocarriers for targeting cancer cells and cancer stem cells. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in
Nanomedicine (Lond) 2015;10:143-60. a mouse model of breast cancer. J Control Release 2013;171:280-7.
95. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg 102. Vinogradov S, Wei X. Cancer stem cells and drug resistance: the
RA, Lander ES. Identification of selective inhibitors of cancer stem potential of nanomedicine. Nanomedicine (Lond) 2012;7:597-615.
cells by high-throughput screening. Cell 2009;138:645-59. 103. Xiao H, Li W, Qi R, Yan L, Wang R, Liu S, Zheng Y, Xie Z,
96. Malhi S, Gu X. Nanocarrier-mediated drugs targeting cancer stem Huang Y, Jing X. Co-delivery of daunomycin and oxaliplatin by
cells: an emerging delivery approach. Expert Opin Drug Deliv biodegradable polymers for safer and more efficacious combination
2015;12:1177-201. therapy. J Control Release 2012;163:304-14.
97. Shen S, Xia JX, Wang J. Nanomedicine-mediated cancer stem cell 104. Kim YJ, Liu Y, Li S, Rohrs J, Zhang R, Zhang X, Wang P. Co-
therapy. Biomaterials 2016;74:1-18. Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-
98. Zhao Y, Alakhova DY, Kabanov AV. Can nanomedicines kill cancer Linked Multilamellar Liposomes Enhances Tumor Treatment. Mol
stem cells? Adv Drug Deliv Rev 2013;65:1763-83. Pharm 2015;12:2811-22.
99. Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer 105. Oak PS, Kopp F, Thakur C, Ellwart JW, Rapp UR, Ullrich A, Wagner
nanotechnology: the impact of passive and active targeting in the E, Knyazev P, Roidl A. Combinatorial treatment of mammospheres
era of modern cancer biology. Adv Drug Deliv Rev 2014;66:2-25. with trastuzumab and salinomycin efficiently targets HER2-positive
100. Liu Y, Rohrs J, Wang P. Advances and challenges in the use of cancer cells and cancer stem cells. Int J Cancer 2012;131:2808-19.

242
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ July 8, 2016 ¦